×

Our new drug could drastically change hemophilia patients' lives, BioMarin CEO says

7:07 PM ET Thu, 10 May 2018

Jim Cramer hears from BioMarin Chairman and CEO Jean-Jacques Bienaimé, who discusses new products in his company's pipeline.